Investigation of expression of myocardial miR-126, miR-29a and miR-222 as a potential marker in STZ- induced diabetic rats following interval and continuous exercise training.

Continuous training Diabetic cardiomyopathy Interval training MicroRNAs

Journal

Journal of diabetes and metabolic disorders
ISSN: 2251-6581
Titre abrégé: J Diabetes Metab Disord
Pays: Switzerland
ID NLM: 101590741

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 03 10 2021
accepted: 07 12 2021
entrez: 8 6 2022
pubmed: 9 6 2022
medline: 9 6 2022
Statut: epublish

Résumé

Cardiac miRNAs are the recently discovered key modulators of gene expression in the heart which have been shown to contribute to both transcriptional and post-transcriptional regulation in diabetic cardiomyopathy. The aim of this study was to evaluate the protective effects of interval and continuous aerobic training on diabetic hearts by examining the expression of myocardial miR-126, miR-222 and miR-29a genes. Thirty male wistar rats (200 ± 20 g) were randomly divided into six groups of healthy control (HC), diabetes control (DC), continuous training (CT), interval training (IT), continuous training with diabetes (CTD), and interval training with diabetes (ITD). Nicotinamide and Streptozotocin (STZ) were injected to induce type 2 diabetes. CT was performed with a speed of 10 to 22 m/min and 20 to 30 min and IT was performed with 10 to 39 m/min and total time of 15 min, five sessions per week for 6 weeks. Muscle expression of miR-126, miR-29a and miR-222 was determined by the RT-PCR method. The results show that gene expression of miR-126 was higher in IT ( Diabetes decreased the expression of genes associated with the development of cardiac function. It seems that IT played a more effective role in cardiac protection than CT through higher miR-126, miR-222 and miR-29a gene expression.

Identifiants

pubmed: 35673452
doi: 10.1007/s40200-021-00957-2
pii: 957
pmc: PMC9167327
doi:

Types de publication

Journal Article

Langues

eng

Pagination

189-195

Informations de copyright

© Springer Nature Switzerland AG 2021.

Déclaration de conflit d'intérêts

Conflict of interestThe authors declare no conflict of interest.

Références

Cell Metab. 2015 Apr 7;21(4):584-95
pubmed: 25863248
Thromb Haemost. 2017 Apr 3;117(4):734-749
pubmed: 28124060
J Cell Mol Med. 2019 Sep;23(9):5859-5867
pubmed: 31240820
Physiol Genomics. 2011 Jun 15;43(11):665-73
pubmed: 21447748
PeerJ. 2018 May 23;6:e4788
pubmed: 29844959
Diabetologia. 2017 Jan;60(1):7-23
pubmed: 27681241
Mol Med Rep. 2017 Oct;16(4):5627-5632
pubmed: 28849170
J Cell Physiol. 2020 Jun;235(6):5229-5240
pubmed: 31823395
Am J Physiol Renal Physiol. 2013 May 15;304(10):F1274-82
pubmed: 23467423
Free Radic Biol Med. 2021 Jun;169:317-342
pubmed: 33910093
Metabolism. 2004 Sep;53(9):1233-42
pubmed: 15334390
Circ Res. 2010 Sep 17;107(6):810-7
pubmed: 20651284
Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13027-32
pubmed: 18723672
Mol Med Rep. 2011 Jul-Aug;4(4):633-40
pubmed: 21584493
Stem Cells Int. 2018 Apr 11;2018:2912347
pubmed: 29760722
Oxid Med Cell Longev. 2014;2014:102158
pubmed: 25215171
ESC Heart Fail. 2021 Apr;8(2):1711-1716
pubmed: 33570253
Cardiol Rev. 2016 Nov/Dec;24(6):273-281
pubmed: 27548688
Braz J Med Biol Res. 2011 Sep;44(9):836-47
pubmed: 21881810
Arch Cardiovasc Dis. 2021 Nov;114(11):748-760
pubmed: 34627704
World J Diabetes. 2021 Apr 15;12(4):383-406
pubmed: 33889286
Pharmacol Res. 2021 Apr;166:105510
pubmed: 33610720
Cardiovasc Diabetol. 2017 Jan 13;16(1):10
pubmed: 28086863
Phys Ther. 2014 Dec;94(12):1720-30
pubmed: 25082918
Nature. 2011 Jan 20;469(7330):336-42
pubmed: 21248840
Cardiovasc Diabetol. 2018 May 11;17(1):67
pubmed: 29751802
Circ Res. 2011 Oct 28;109(10):1115-9
pubmed: 21903938
Med Sci Sports Exerc. 2021 Mar 1;53(3):559-573
pubmed: 32890201
J Cell Mol Med. 2020 Nov;24(22):12970-12979
pubmed: 32939968
Arch Med Res. 2017 Jan;48(1):27-34
pubmed: 28577867
Circ J. 2011;75(2):336-40
pubmed: 21157109
Curr Pharm Des. 2017;23(22):3309-3314
pubmed: 28440196
Life Sci. 2021 Jan 1;264:118697
pubmed: 33130084
Oxid Med Cell Longev. 2017;2017:7921363
pubmed: 28698769

Auteurs

Javad Akbari (J)

Exercise Physiology Research Center, Life Style Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Hossein Shirvani (H)

Exercise Physiology Research Center, Life Style Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Alireza Shamsoddini (A)

Exercise Physiology Research Center, Life Style Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Behzad Bazgir (B)

Exercise Physiology Research Center, Life Style Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Mohammad Samadi (M)

Exercise Physiology Research Center, Life Style Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Classifications MeSH